Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK
Authors:
- Julian F. GuestJGJulian F. Guest
- Ritva HurskainenRHRitva Hurskainen
- 23 May 2007
- journal article
- research article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 23 (7) , 1637-1648
Abstract
To estimate the cost-utility of levonorgestrel intrauterine system (LNG-IUS; Mirena) compared to second generation endometrial ablative techniques [i.e. microwave endometrial ablation (MEA) and thermal balloon endometrial ablation (TBEA)) and hysterectomy in the UK. Clinical and utility data from a 5-year randomised controlled trial comparing LNG-IUS with hysterectomy were combined with further data from published studies to construct a state-transition (Markov) model. The model depicted the movement of patients between health states over 5 years following treatment for menorrhagia. The model was used to estimate the cost-utility of LNG-IUS followed by ablation (L-A); LNG-IUS followed by hysterectomy (L-H); immediate ablation (MEA or TBEA) and immediate hysterectomy in the UK at 2004/2005 prices, from the perspective of the UK's National Health Service (NHS). The expected 5-yearly cost of treating menorrhagia with L-A, L-H, TBEA, MEA and hysterectomy was estimated to be 828 pounds sterling, 1355 pounds sterling, 1679 pounds sterling, 1812 pounds sterling and 2983 pounds sterling per patient respectively and the expected level of health gain to be 4.14, 4.12, 4.13, 4.13 and 4.01 QALYs per patient respectively. LNG-IUS followed by ablation dominated all the alternative treatments. Hysterectomy was dominated by the alternative treatments. Sensitivity analysis found the model to be sensitive to the quality of life data used. Within the model's limitations, LNGIUS followed by ablation appears to offer the NHS a cost-effective treatment for menorrhagia, when compared to immediate surgery, affording the NHS a less expensive treatment modality without detrimental effects on resulting health gain.Keywords
This publication has 20 references indexed in Scilit:
- A cost–utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleedingBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- FFPRHC Guidance (April 2004): The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive healthBMJ Sexual & Reproductive Health, 2004
- Clinical Outcomes and Costs With the Levonorgestrel-Releasing Intrauterine System or Hysterectomy for Treatment of MenorrhagiaJAMA, 2004
- A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four yearsBJOG: An International Journal of Obstetrics & Gynaecology, 1999
- Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomyCommentary: Promising results but wider recruitment neededBMJ, 1998
- Endometrial resection versus vaginal hysterectomy for menorrhagia: Long-term clinical and quality-of-life outcomesAmerican Journal of Obstetrics and Gynecology, 1997
- Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleedingBMJ, 1994
- Evaluation of surgical options in menorrhagiaBJOG: An International Journal of Obstetrics & Gynaecology, 1994
- A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia.BMJ, 1991
- Menstrual Blood Loss–A Population StudyActa Obstetricia et Gynecologica Scandinavica, 1966